Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury
Clinical trial NCT03992404 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03992404
- Sponsor
- Merz Pharmaceuticals GmbH
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-16
- Primary completion
- 2025-06-19
- Enrollment
- 603
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.